Kristina Busygina
17  Ergebnisse:
Personensuche X
?
1

Association of GLP-1 secretion with parameters of glycemic ..:

Pappa, Eleni ; Busygina, Kristina ; Harada, Saori...
BMJ Open Diabetes Research & Care.  12 (2024)  1 - p. e003706 , 2024
 
?
5

Die Verordnung von PCSK9-Inhibitoren ist klar geregelt:

Busygina, Kristina ; Parhofer, Klaus G.
MMW - Fortschritte der Medizin.  160 (2018)  1 - p. 43-46 , 2018
 
?
10

Effect of PCSK9 inhibition with evolocumab on lipoprotein s..:

Elisa Waldmann ; Liya Wu ; Kristina Busygina...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942248/?tool=EBI.  , 2022
 
?
 
?
14

Btk Inhibitors as First Oral Atherothrombosis-Selective Ant..:

Busygina, Kristina ; Denzinger, Viola ; Bernlochner, Isabell...
Busygina , K , Denzinger , V , Bernlochner , I , Weber , C , Lorenz , R & Siess , W 2019 , ' Btk Inhibitors as First Oral Atherothrombosis-Selective Antiplatelet Drugs? ' , Thrombosis and Haemostasis , vol. 119 , no. 8 , pp. 1212-1221 . https://doi.org/10.1055/s-0039-1687877.  , 2019
 
?
15

Oral Bruton tyrosine kinase inhibitors selectively block at..:

Busygina, Kristina ; Jamasbi, Janina ; Seiler, Till...
Busygina , K , Jamasbi , J , Seiler , T , Deckmyn , H , Weber , C , Brandl , R , Lorenz , R & Siess , W 2018 , ' Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque-triggered thrombus formation in humans ' , Blood , vol. 131 , no. 24 , pp. 2605-2616 . https://doi.org/10.1182/blood-2017-09-808808.  , 2018
 
1-15